Search

everythinglearnresearchcommunity

for

Search:↓

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Alopecia in transgender individuals on hormone therapy can worsen emotional distress and affect self-esteem.

There is unequal access to gender-affirming surgeries in Canada, with a need for better coverage and specialized programs.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Topical 3% minoxidil effectively and safely enhances facial hair in transgender men.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Understanding sex and gender differences can improve personalized dermatology care.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

Create safe, inclusive choir spaces for transgender singers with supportive language and programming.

Transgender youth on hormone therapy need personalized acne treatments and supportive care.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.

Facial feminization surgery is effective in helping transgender women appear more feminine and has high patient satisfaction.

Lip feminization is important for transgender women, requiring personalized approaches and expert consultation for best results.

Bicalutamide may help treat female pattern hair loss.

Clascoterone cream 1% is effective and well-tolerated for treating acne and other related conditions.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Transgender patients face more barriers to oral healthcare, leading to poorer oral health and quality of life.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Sex hormones, especially estradiol, can change chicken feather shapes and colors.